Etomidate Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Etomidate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 10/05/2022.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-6695-01
Dosage Form
Injection
Presentation
Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)
Initial Posting
10/05/2022
Revised Date